Projects per year
Personal profile
About
Ariel Perez Perez, M.D., is a hematologist and medical oncologist at Miami Cancer Institute. Dr. Perez Perez specializes in bone marrow transplant, cellular immunotherapy and malignant hematology. He is fluent in English and Spanish. Dr. Perez Perez joined Miami Cancer Institute from the H. Lee Moffitt Cancer Center & Research Institute in Tampa, where he completed a fellowship in bone marrow transplant and cellular immunotherapy. During his fellowship, he was involved in clinical research in CAR T-cell therapy for patients with relapsed refractory B-cell lymphomas. He served as chief resident and chief fellow during his residency and fellowship programs. Dr. Perez Perez earned several academic achievement awards, including the Internal Medicine and Hematology-Oncology Academic Achievement Awards at Orlando Health. He also graduated medical school with honors (Summa Cum Laude). Dr. Perez Perez’s research has been published in peer-reviewed publications, including the Transplantation and Cellular Therapy Journal, Journal of Clinical Oncology, Journal of Thoracic Oncology and Annals of Oncology. He has also presented his research at numerous research meetings, industry conferences and events. Dr. Perez Perez’s approach to patient care is to establish and maintain communication and trust with his patients while providing the highest level of evidence-based medical care.
Related documents
Education/Academic qualification
Hematology Oncology, Fellowship, US Health Cancer Center at Orlando Health, Orlando, FL
2017 → 2020
Internal Medicine, Resident, Orlando Health, Orlando, FL
2014 → 2017
Resident, National Institute of Oncology and Radiobiology, Havana, Cuba
2007 → 2011
Family Medicine, Resident, University of Medical Sciences, Havana, Cuba
2004 → 2007
Doctor in Medicine, University of Medical Sciences. Havana Cuba
1998 → 2004
Bachelor in Sciences, IPVCE Vladimir I Lenin
1994 → 1997
Fellowship, Moffitt Cancer Center, Tampa, FL
2021 → …
External positions
Resident, National Institute of Oncology and Radiobiology, Havana, Cuba
May 1 2011 → May 1 2012
Disciplines
- Medicine and Health Sciences
Projects
- 3 Finished
-
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults with Systemic Lupus Erythematosus
Perez, A. P. (PI) & Saporta, M. (CoI)
1/1/21 → 1/1/24
Project: Research project
-
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults with Systemic Lupus Erythematosus
Perez, A. P. (PI) & Carpintero, M. (CoI)
Eli Lilly and Company / Nektar Therapeutics
1/1/20 → 1/1/23
Project: Research project
-
Design and conduction of early phase clinical trials in hematological and non-hematological malignancies
Perez, A. P. (PI) & Gracia, E. (CoI)
National Institute of Oncology and Radiobiology
1/1/11 → 1/1/12
Project: Research project
-
On-target, off-tumor oral toxicities of talquetamab in heavily pretreated multiple myeloma
Alves, F. A., Perez Perez, A., Jaguar, G. C., Filho, J. S., Kim, M. K. & Villa, A., Apr 2026, In: Supportive Care in Cancer. 34, 4, 347.Research output: Contribution to journal › Review article › peer-review
Open Access -
Efficacy of pemetrexed-based regimens in primary central nervous system lymphoma: A single-center experience.
Kehtari, T., Reddy, R., Perez Perez, A., Odia, Y., Al Sagheer, T., Ahluwalia, M. S., Chen, Z., Nahas, G. R., Rubens, M. & Linhares, Y., Jun 2025, In: Journal of Clinical Oncology. 43, p. e19078-e19078Research output: Contribution to journal › Review article › peer-review
-
Novel Therapies in Primary Central Nervous System Lymphoma
Wakim, M., Mezher, M., Perez-Perez, A., Maharaj, A., Odia, Y., Ahluwalia, M. S. & Linhares, Y., 2025, In: Clinical Pharmacology: Advances and Applications. 17, p. 97-117 21 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Outpatient administration of CAR T-cell therapy: a focused review with recommendations for implementation in community based centers
Perez, A., Al Sagheer, T., Nahas, G. R. & Linhares, Y. P. L., 2024, In: Frontiers in immunology. 15, p. 1412002Research output: Contribution to journal › Review article › peer-review
-
A Phase 2 Multicenter Trial of Ofatumumab and Prednisone as Initial Therapy of Chronic Graft-vs-Host Disease.
Perez Perez, A. & and institutional affiliations, A. A., Jan 2022, In: Blood Advances. 11Research output: Contribution to journal › Article › peer-review
-
-
-
American Society of Clinical Oncology (External organization)
Perez Perez, A. (Member)
Jan 1 2017 → …Activity: Membership › Membership of network
-
UF Health Cancer Center at Orlando Health
Perez Perez, A. (Member)
Jan 1 2017 → Jan 1 2020Activity: Other
-
American Society of Hematology (External organization)
Perez Perez, A. (Member)
Jan 1 2017 → …Activity: Membership › Membership of network
Prizes
-
2004 Award for Academic Achievement. University of Medical Sciences, Havana, Cuba
Perez Perez, A. (Recipient), 2004
Prize: Prize (including medals and awards)
-
2011 Award for Academic Achievement. National Institute of Oncology and Radiobiology
Perez Perez, A. (Recipient), 2011
Prize: Prize (including medals and awards)
-
2014-2016 Annual In-Training Examination Award. Orlando Health, Internal Medicine Program
Perez Perez, A. (Recipient), 2014
Prize: Prize (including medals and awards)
-
2015 ACP Medical Jeopardy Florida State Champion
Perez Perez, A. (Recipient), 2015
Prize: Prize (including medals and awards)
-
2016 ACP Medical Jeopardy International Championship Top 20 Battle Rounds
Perez Perez, A. (Recipient), 2016
Prize: Prize (including medals and awards)